TickerFacts.

Processa Pharmaceuticals, Inc. (PCSA): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-20, first reflected in a filing dated 2024-03-29; 1-for-25, first reflected in a filing dated 2026-03-18. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

2.57M
As of 2025-12-31
2.79M
As of 2026-06-30
35.27M2013-12-31: 8.08M2014-12-31: 10.95M2015-12-31: 11.02M2016-12-31: 31.75M2017-12-31: 35.27M2018-12-31: 5.53M2019-12-31: 5.49M2020-12-31: 14.18M2021-12-31: 15.71M2022-12-31: 801.8K2023-12-31: 1.29M2024-12-31: 148.1K2025-12-31: 2.57M2.57M
2013-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-312.57Mn/m2026-03-18, Balance as of period end
2024-12-31148.1Kn/c2026-03-18, Balance as of period end
2023-12-311.29M+60.4%2025-03-20, Balance as of period end
2022-12-31801.8Kn/c2024-03-29, Balance as of period end
2021-12-3115.71M+10.8%2023-03-30, Balance as of period end
2020-12-3114.18M+158.5%2022-03-30, Balance as of period end
2019-12-315.49M-0.7%2021-03-25, Balance as of period end
2018-12-315.53M-84.3%2020-03-06, Balance as of period end
2017-12-3135.27M+11.1%2019-04-08, Balance as of period end
2016-12-3131.75Mn/c2018-04-16, Balance as of period end
2015-12-3111.02M+0.6%2017-09-25, Balance as of period end
2014-12-3110.95M+35.5%2017-06-19, Balance as of period end
2013-12-318.08Mn/a2015-04-14, Balance as of period end